Huaren Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 800.89 million compared to CNY 717.55 million a year ago. Revenue was CNY 829.05 million compared to CNY 721.96 million a year ago.

Net income was CNY 82.28 million compared to CNY 74.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.0696 compared to CNY 0.0627 a year ago. Diluted earnings per share from continuing operations was CNY 0.0696 compared to CNY 0.0627 a year ago.